Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7813573rdf:typepubmed:Citationlld:pubmed
pubmed-article:7813573lifeskim:mentionsumls-concept:C0597357lld:lifeskim
pubmed-article:7813573lifeskim:mentionsumls-concept:C0243192lld:lifeskim
pubmed-article:7813573lifeskim:mentionsumls-concept:C0205100lld:lifeskim
pubmed-article:7813573lifeskim:mentionsumls-concept:C0292970lld:lifeskim
pubmed-article:7813573pubmed:issue1-2lld:pubmed
pubmed-article:7813573pubmed:dateCreated1995-2-8lld:pubmed
pubmed-article:7813573pubmed:abstractTextIn the guinea-pig isolated ileum, both baclofen and gamma-guanidinobaclofen elicited dose-dependent depression of cholinergic twitch contractions, sensitive to the GABAB receptor antagonists phaclofen and 2-hydroxysaclofen. gamma-Guanidinobaclofen was 5 times less potent than R,S-(+/-)-baclofen in depressing the contractions. The corresponding GABA analogs, guanidinoacetic acid, beta-guanidinopropionic acid and gamma-guanidinobutanoic acid were inactive. In rat neocortical slices maintained in Mg(2+)-free medium, baclofen (1-50 microM) reduced the amplitude and rate, whilst gamma-guanidinobaclofen (1 mM) has a very weak GABAB receptor agonist action, 100 times weaker than baclofen. gamma-Guanidinobaclofen is therefore a GABAB receptor agonist, more potent at peripheral than central GABAB receptors.lld:pubmed
pubmed-article:7813573pubmed:languageenglld:pubmed
pubmed-article:7813573pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7813573pubmed:citationSubsetIMlld:pubmed
pubmed-article:7813573pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7813573pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7813573pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7813573pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7813573pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7813573pubmed:statusMEDLINElld:pubmed
pubmed-article:7813573pubmed:monthSeplld:pubmed
pubmed-article:7813573pubmed:issn0014-2999lld:pubmed
pubmed-article:7813573pubmed:authorpubmed-author:KerrD IDIlld:pubmed
pubmed-article:7813573pubmed:authorpubmed-author:LIT KTKlld:pubmed
pubmed-article:7813573pubmed:authorpubmed-author:HumeniukR ERElld:pubmed
pubmed-article:7813573pubmed:issnTypePrintlld:pubmed
pubmed-article:7813573pubmed:day1lld:pubmed
pubmed-article:7813573pubmed:volume262lld:pubmed
pubmed-article:7813573pubmed:ownerNLMlld:pubmed
pubmed-article:7813573pubmed:authorsCompleteYlld:pubmed
pubmed-article:7813573pubmed:pagination189-92lld:pubmed
pubmed-article:7813573pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:7813573pubmed:meshHeadingpubmed-meshheading:7813573-...lld:pubmed
pubmed-article:7813573pubmed:meshHeadingpubmed-meshheading:7813573-...lld:pubmed
pubmed-article:7813573pubmed:meshHeadingpubmed-meshheading:7813573-...lld:pubmed
pubmed-article:7813573pubmed:meshHeadingpubmed-meshheading:7813573-...lld:pubmed
pubmed-article:7813573pubmed:meshHeadingpubmed-meshheading:7813573-...lld:pubmed
pubmed-article:7813573pubmed:meshHeadingpubmed-meshheading:7813573-...lld:pubmed
pubmed-article:7813573pubmed:meshHeadingpubmed-meshheading:7813573-...lld:pubmed
pubmed-article:7813573pubmed:meshHeadingpubmed-meshheading:7813573-...lld:pubmed
pubmed-article:7813573pubmed:meshHeadingpubmed-meshheading:7813573-...lld:pubmed
pubmed-article:7813573pubmed:meshHeadingpubmed-meshheading:7813573-...lld:pubmed
pubmed-article:7813573pubmed:meshHeadingpubmed-meshheading:7813573-...lld:pubmed
pubmed-article:7813573pubmed:meshHeadingpubmed-meshheading:7813573-...lld:pubmed
pubmed-article:7813573pubmed:meshHeadingpubmed-meshheading:7813573-...lld:pubmed
pubmed-article:7813573pubmed:meshHeadingpubmed-meshheading:7813573-...lld:pubmed
pubmed-article:7813573pubmed:meshHeadingpubmed-meshheading:7813573-...lld:pubmed
pubmed-article:7813573pubmed:meshHeadingpubmed-meshheading:7813573-...lld:pubmed
pubmed-article:7813573pubmed:year1994lld:pubmed
pubmed-article:7813573pubmed:articleTitleGamma-guanidinobaclofen is a peripheral GABAB receptor agonist.lld:pubmed
pubmed-article:7813573pubmed:affiliationDepartment of Anaesthesia and Intensive Care, University of Adelaide, Australia.lld:pubmed
pubmed-article:7813573pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7813573pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed